Kerbala Journal of Pharmaceutical Sciences · Jun 30, 2026

Osterix Gene Expression in Women with Osteoporosis and Its Association with Biomarkers of Bone Remodeling and Hormone Levels According to Menopausal Status

By Kazem AF, Albazi WJ, yahya MW

Background: The aim of the current study is to reveal the gene expression of the Osterix gene and its relationship to bone regeneration and hormonal indicators in women with osteoporosis according to their physiological menopausal status, the current study was conducted after obtaining the necessary ethical approvals from the relevant authorities. Methodology: Samples were collected from women with osteoporosis, aged 39 to 60 years, 40 of whom were premenopausal and 50 postmenopausal. Estrogen, vitamin D, and parathyroid hormone levels were measured, as were calcium, phosphorus, and alkaline phosphatase levels in the patients' serum using the appropriate kit for each test. Osterix gene expression was also measured using quantitative real-time polymerase chain reaction (RT-qPCR). Results: The results showed that postmenopausal women with osteoporosis had statistically significant decreases in estrogen, vitamin D, and calcium levels, as well as statistically significant increases in parathyroid hormone and alkaline phosphatase levels, compared with premenopausal women with osteoporosis. Conclusion: The results also showed a significant decrease in Osterix gene expression in postmenopausal women compared to premenopausal women, and correlation analysis revealed a positive relationship between estrogen levels and Osterix gene expression for all women.

doi.org/10.62472/kjps.v17.i28.238-248Open accessMechanisms

AgingResearch.News